Clinical trial
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With…
NCT00002719 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002719 |
|---|---|
| Title | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia |
| Official title | RANDOMIZED PHASE III STUDY TO EVALUATE THE VALUE OF rHuG-CSF IN INDUCTION AND OF AN ORAL SCHEDULE AS CONSOLIDATION TREATMENT IN ELDERLY PATIENTS WITH ACUTE MYELOGENOUS LEUMEKIA (AML-13 PROTOCOL) |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | Gruppo Italiano Malattie EMatologiche dell'Adulto |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Neutropenia |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, amsacrine, carmustine, cytarabine, etoposide, idarubicin, mitoxantrone hydrochloride, peripheral blood stem cell transplantation |
| Enrollment | 500 |
| Start date | Dec 1, 1995 |
| Primary completion | Nov 1, 2001 |
| First posted | Apr 29, 2004 |
| Last update posted | Jul 2, 2012 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: